Intensive care accessibility and outcomes in pandemics
- PMID: 33052422
- PMCID: PMC7556548
- DOI: 10.1007/s00134-020-06264-3
Intensive care accessibility and outcomes in pandemics
Conflict of interest statement
FGZ has received grants for investigator-initiated clinical trials from Bactiguard, Sweden, and Ionis Pharmaceuticals, USA, in the past 5 years. FGZ has also received grants from the Brazilian Ministry of Health to conduct research, including observational studies, in Brazil through the Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde (PROADI-SUS). FGZ has not received direct compensation, travel support, or holds stock market shares from any pharmaceutical company. Markus B Skrifvars has received travel grants and speaker’s fees from BARD Medical (Ireland) and a research grant from GE Healthcare. JA has no conflicts of interest to declare.
Figures
Comment on
-
Access to intensive care in 14 European countries: a spatial analysis of intensive care need and capacity in the light of COVID-19.Intensive Care Med. 2020 Nov;46(11):2026-2034. doi: 10.1007/s00134-020-06229-6. Epub 2020 Sep 4. Intensive Care Med. 2020. PMID: 32886208 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
